![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Syneos Health Inc | NASDAQ:SYNH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 42.98 | 42.96 | 42.99 | 0 | 01:00:00 |
The development of this unique digital asset underscores Syneos Health’s continued focus on Medical Affairs, an increasingly critical component of successful clinical development. Fueled by the Company’s advanced digital engagement capabilities and data-enabled technology solutions, the program includes two components that can work together or independently, helping to develop flexible and tailored solutions for customers’ needs:
“Medical innovation is constantly advancing, while data is exponentially increasing in volume and complexity. Our Medical Affairs team serves as the hub and conduit to accelerate knowledge consumption, enabling our customers to have more meaningful engagement with the healthcare communities they serve,” said Suma Ramadas, PhD, Executive Vice President, Medical Affairs, Syneos Health. “Medical Affairs Digital Amplifier elevates our deep domain expertise by enabling greater reach and impact for our customers’ medical education strategies. We’re excited to bring this technology-based program forward, further advancing our customers’ performance to change patients’ lives.”
The launch of Medical Affairs Digital Amplifier continues the Company’s investment in differentiating technology and data solutions that aim to amplify biopharmaceutical customers’ success across the clinical to commercial continuum.
About Syneos HealthSyneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
Investor Relations Contact: Ronnie SpeightSenior Vice President, Investor Relations+1 919 745 2745Investor.Relations@syneoshealth.com | Press/Media Contact:Gary GatyasExecutive Director, External Communications+1 908 763 3428 gary.gatyas@syneoshealth.com |
1 Year Syneos Health Chart |
1 Month Syneos Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions